General Motors Company (GM)vsWest Pharmaceutical Services Inc (WST)
GM
General Motors Company
$78.80
+0.50%
CONSUMER CYCLICAL · Cap: $70.70B
WST
West Pharmaceutical Services Inc
$325.92
+1.21%
HEALTHCARE · Cap: $22.08B
Smart Verdict
WallStSmart Research — data-driven comparison
General Motors Company generates 5632% more annual revenue ($184.62B vs $3.22B). WST leads profitability with a 16.9% profit margin vs 1.4%. GM appears more attractively valued with a PEG of 0.34. WST earns a higher WallStSmart Score of 67/100 (B-).
GM
Buy52
out of 100
Grade: C-
WST
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+24.0%
Fair Value
$105.05
Current Price
$78.80
$26.25 discount
Margin of Safety
-32.4%
Fair Value
$185.95
Current Price
$325.92
$139.97 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Reasonable price relative to book value
Large-cap with strong market position
Generating 1.4B in free cash flow
Earnings expanding 56.1% YoY
Safe zone — low bankruptcy risk
Strong operational efficiency at 21.7%
Revenue surging 21.0% year-over-year
Areas to Watch
Moderate valuation
ROE of 4.0% — below average capital efficiency
1.4% margin — thin
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : GM
The strongest argument for GM centers on PEG Ratio, Price/Book, Market Cap. PEG of 0.34 suggests the stock is reasonably priced for its growth.
Bull Case : WST
The strongest argument for WST centers on EPS Growth, Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.9% and operating margin at 21.7%. Revenue growth of 21.0% demonstrates continued momentum.
Bear Case : GM
The primary concerns for GM are P/E Ratio, Return on Equity, Profit Margin. Thin 1.4% margins leave little buffer for downturns.
Bear Case : WST
The primary concerns for WST are PEG Ratio, P/E Ratio. A P/E of 41.8x leaves little room for execution misses.
Key Dynamics to Monitor
GM profiles as a value stock while WST is a growth play — different risk/reward profiles.
GM carries more volatility with a beta of 1.29 — expect wider price swings.
WST is growing revenue faster at 21.0% — sustainability is the question.
GM generates stronger free cash flow (1.4B), providing more financial flexibility.
Bottom Line
WST scores higher overall (67/100 vs 52/100), backed by strong 16.9% margins and 21.0% revenue growth. GM offers better value entry with a 24.0% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
General Motors Company
CONSUMER CYCLICAL · AUTO MANUFACTURERS · USA
General Motors Company (GM) is an American multinational corporation headquartered in Detroit, Michigan that designs, manufactures, markets, and distributes vehicles and vehicle parts, and sells financial services, with global headquarters in Detroit's Renaissance Center.
West Pharmaceutical Services Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
Compare with Other AUTO MANUFACTURERS Stocks
Want to dig deeper into these stocks?